127 related articles for article (PubMed ID: 11307146)
21. The expression and localization of somatostatin receptors in dorsal root ganglion neurons of normal and monoarthritic rats.
Bär KJ; Schurigt U; Scholze A; Segond Von Banchet G; Stopfel N; Bräuer R; Halbhuber KJ; Schaible HG
Neuroscience; 2004; 127(1):197-206. PubMed ID: 15219682
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets.
Lichtenauer-Kaligis EG; Dalm VA; Oomen SP; Mooij DM; van Hagen PM; Lamberts SW; Hofland LJ
Eur J Endocrinol; 2004 Apr; 150(4):565-77. PubMed ID: 15080788
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.
Remke M; Hering E; Gerber NU; Kool M; Sturm D; Rickert CH; Gerß J; Schulz S; Hielscher T; Hasselblatt M; Jeibmann A; Hans V; Ramaswamy V; Taylor MD; Pietsch T; Rutkowski S; Korshunov A; Monoranu CM; Frühwald MC
Childs Nerv Syst; 2013 Aug; 29(8):1253-62. PubMed ID: 23677175
[TBL] [Abstract][Full Text] [Related]
24. Expression of somatostatin receptor subtypes on guinea pig gastric and colonic smooth muscle cells.
Corleto VD; Weber HC; Jensen RT
Am J Physiol; 1999 Jul; 277(1):G235-44. PubMed ID: 10409172
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin (SRIF) and SRIF receptors in the mouse retina.
Cristiani R; Petrucci C; Dal Monte M; Bagnoli P
Brain Res; 2002 May; 936(1-2):1-14. PubMed ID: 11988224
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration.
Lambooij AC; Kuijpers RW; van Lichtenauer-Kaligis EG; Kliffen M; Baarsma GS; van Hagen PM; Mooy CM
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2329-35. PubMed ID: 10892880
[TBL] [Abstract][Full Text] [Related]
27. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
Chen C; Chen L; Yao Y; Qin Z; Chen H
J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptor scintigraphy in the differential diagnosis of meningioma.
Bohuslavizki KH; Brenner W; Braunsdorf WE; Behnke A; Tinnemeyer S; Hugo HH; Jahn N; Wolf H; Sippel C; Clausen M; Mehdorn HM; Henze E
Nucl Med Commun; 1996 Apr; 17(4):302-10. PubMed ID: 8786866
[TBL] [Abstract][Full Text] [Related]
30. Expression of somatostatin subtype 1 receptor in the rabbit retina.
Cristiani R; Fontanesi G; Casini G; Petrucci C; Viollet C; Bagnoli P
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3191-9. PubMed ID: 10967083
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K
Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease.
Pasquali D; Notaro A; Bonavolonta' G; Vassallo P; Bellastella A; Sinisi AA
J Clin Endocrinol Metab; 2002 Nov; 87(11):5125-9. PubMed ID: 12414882
[TBL] [Abstract][Full Text] [Related]
33. The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.
O'Toole D; Saveanu A; Couvelard A; Gunz G; Enjalbert A; Jaquet P; Ruszniewski P; Barlier A
Eur J Endocrinol; 2006 Dec; 155(6):849-57. PubMed ID: 17132755
[TBL] [Abstract][Full Text] [Related]
34. Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.
Binderup T; Knigge U; Mellon Mogensen A; Palnaes Hansen C; Kjaer A
Neuroendocrinology; 2008; 87(4):223-32. PubMed ID: 18196892
[TBL] [Abstract][Full Text] [Related]
35. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
[TBL] [Abstract][Full Text] [Related]
36. Expression of somatostatin receptor subtypes in human brain tumors.
Dutour A; Kumar U; Panetta R; Ouafik L; Fina F; Sasi R; Patel YC
Int J Cancer; 1998 May; 76(5):620-7. PubMed ID: 9610716
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
[TBL] [Abstract][Full Text] [Related]
39. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
Ramírez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
